Laxminarayan

Transferrin Receptor-Mediated Nanoparticle Delivery Across the Blood-Brain Barrier for Glioblastoma Therapy

Glioblastoma (GBM) remains the most aggressive of primary brain tumours, with short patient survival despite improvements in surgical resection, radiotherapeutic and chemotherapeutic strategies. One of the main challenges for therapy is to transport anticancer drugs in a broad spectrum, prevent their premature systemic...